While the roles of APOBEC3A and APOBEC3B in bladder cancer have not been functionally explored, transgenic overexpression of APOBEC3G in a BBN-induced carcinogen mouse model of bladder cancer has documented that APOBEC3G can shorten survival as well as drive genomic instability19. This evidence concerns the gene APOBEC3B and urinary bladder carcinoma.